Insurance coverage for focal therapy procedures, such as High-Intensity Focused Ultrasound (HIFU) or focal laser ablation for prostate cancer, varies widely depending on the specific commercial insurance provider, state regulations, and individual policy terms. While Medicare and major private health insurers have increasingly expanded coverage criteria as clinical data supporting focal therapy's efficacy matures, many policies still classify certain robotic focal modalities as investigational or subject to rigorous prior authorization requirements. Patients are strongly encouraged to work closely with their urologist's billing team and insurance navigators to obtain pre-approval and verify out-of-pocket financial responsibilities before scheduling treatment.